Loading…
Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright...
Saved in:
| Published in: | Human psychopharmacology 2005-04, Vol.20 (3), p.203-205 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3 |
| container_end_page | 205 |
| container_issue | 3 |
| container_start_page | 203 |
| container_title | Human psychopharmacology |
| container_volume | 20 |
| creator | Oechsner, Matthias Korchounov, Alexei |
| description | This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd. |
| doi_str_mv | 10.1002/hup.682 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19431692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19431692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMo7rqK_0Bycg_SNR9t03gREb9gQQ96Ltl06kbbpCYtS_31RnbBk6eZ4X14YF6ETilZUELY5XroFnnB9tCUEikTSoTYR1NSFFmSM8Ym6CiED0JiRuQhmtBMxI3SKXIvyoPtwasGf5vOq2AqZ-EKK2xhg1U_dkbHzMLgXQNdbzSuncfQgn8Hq0fce1B9Gx3Y1bgLo167YAI2Fkf1p7HB2XnAlQmgAlwfo4NaNQFOdnOG3u7vXm8fk-Xzw9PtzTLRXEiWcJ4WnGWUa1UVeZUVKeGSs5UkOVN5BWn8ZcVFnclciFUkVFGlhaC1qOINms_Q-dbbefc1QOjL1gQNTaMsuCGUVKac5pJFcL4FtXcheKjLzptW-bGkpPzttozdlrHbSJ7tlMOqheqP25UZgYstsDENjP95yse3l1_dD0Bpg30</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19431692</pqid></control><display><type>article</type><title>Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Oechsner, Matthias ; Korchounov, Alexei</creator><creatorcontrib>Oechsner, Matthias ; Korchounov, Alexei</creatorcontrib><description>This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd.</description><identifier>ISSN: 0885-6222</identifier><identifier>EISSN: 1099-1077</identifier><identifier>DOI: 10.1002/hup.682</identifier><identifier>PMID: 15799011</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Aged ; Antiparkinson Agents - therapeutic use ; Antipsychotic Agents - administration & dosage ; Antipsychotic Agents - adverse effects ; Antipsychotic Agents - therapeutic use ; Electrocardiography ; Emergency Medical Services ; Female ; Humans ; Injections, Intramuscular ; Male ; Middle Aged ; neuroleptic ; Parkinson Disease - complications ; Parkinson Disease - drug therapy ; Parkinson Disease - psychology ; Parkinson's disease ; Piperazines - administration & dosage ; Piperazines - adverse effects ; Piperazines - therapeutic use ; Psychiatric Status Rating Scales ; Psychomotor Agitation - drug therapy ; Psychomotor Agitation - etiology ; psychosis ; Psychotic Disorders - drug therapy ; Psychotic Disorders - etiology ; Psychotic Disorders - psychology ; Thiazoles - administration & dosage ; Thiazoles - adverse effects ; Thiazoles - therapeutic use ; treatment ; ziprasidone</subject><ispartof>Human psychopharmacology, 2005-04, Vol.20 (3), p.203-205</ispartof><rights>Copyright © 2005 John Wiley & Sons, Ltd.</rights><rights>Copyright (c) 2005 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3</citedby><cites>FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15799011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oechsner, Matthias</creatorcontrib><creatorcontrib>Korchounov, Alexei</creatorcontrib><title>Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?</title><title>Human psychopharmacology</title><addtitle>Hum Psychopharmacol</addtitle><description>This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd.</description><subject>Aged</subject><subject>Antiparkinson Agents - therapeutic use</subject><subject>Antipsychotic Agents - administration & dosage</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Electrocardiography</subject><subject>Emergency Medical Services</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intramuscular</subject><subject>Male</subject><subject>Middle Aged</subject><subject>neuroleptic</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - psychology</subject><subject>Parkinson's disease</subject><subject>Piperazines - administration & dosage</subject><subject>Piperazines - adverse effects</subject><subject>Piperazines - therapeutic use</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychomotor Agitation - drug therapy</subject><subject>Psychomotor Agitation - etiology</subject><subject>psychosis</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Psychotic Disorders - etiology</subject><subject>Psychotic Disorders - psychology</subject><subject>Thiazoles - administration & dosage</subject><subject>Thiazoles - adverse effects</subject><subject>Thiazoles - therapeutic use</subject><subject>treatment</subject><subject>ziprasidone</subject><issn>0885-6222</issn><issn>1099-1077</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LxDAQhoMo7rqK_0Bycg_SNR9t03gREb9gQQ96Ltl06kbbpCYtS_31RnbBk6eZ4X14YF6ETilZUELY5XroFnnB9tCUEikTSoTYR1NSFFmSM8Ym6CiED0JiRuQhmtBMxI3SKXIvyoPtwasGf5vOq2AqZ-EKK2xhg1U_dkbHzMLgXQNdbzSuncfQgn8Hq0fce1B9Gx3Y1bgLo167YAI2Fkf1p7HB2XnAlQmgAlwfo4NaNQFOdnOG3u7vXm8fk-Xzw9PtzTLRXEiWcJ4WnGWUa1UVeZUVKeGSs5UkOVN5BWn8ZcVFnclciFUkVFGlhaC1qOINms_Q-dbbefc1QOjL1gQNTaMsuCGUVKac5pJFcL4FtXcheKjLzptW-bGkpPzttozdlrHbSJ7tlMOqheqP25UZgYstsDENjP95yse3l1_dD0Bpg30</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Oechsner, Matthias</creator><creator>Korchounov, Alexei</creator><general>John Wiley & Sons, Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200504</creationdate><title>Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?</title><author>Oechsner, Matthias ; Korchounov, Alexei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Antiparkinson Agents - therapeutic use</topic><topic>Antipsychotic Agents - administration & dosage</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Electrocardiography</topic><topic>Emergency Medical Services</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intramuscular</topic><topic>Male</topic><topic>Middle Aged</topic><topic>neuroleptic</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - psychology</topic><topic>Parkinson's disease</topic><topic>Piperazines - administration & dosage</topic><topic>Piperazines - adverse effects</topic><topic>Piperazines - therapeutic use</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychomotor Agitation - drug therapy</topic><topic>Psychomotor Agitation - etiology</topic><topic>psychosis</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Psychotic Disorders - etiology</topic><topic>Psychotic Disorders - psychology</topic><topic>Thiazoles - administration & dosage</topic><topic>Thiazoles - adverse effects</topic><topic>Thiazoles - therapeutic use</topic><topic>treatment</topic><topic>ziprasidone</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oechsner, Matthias</creatorcontrib><creatorcontrib>Korchounov, Alexei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Human psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oechsner, Matthias</au><au>Korchounov, Alexei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?</atitle><jtitle>Human psychopharmacology</jtitle><addtitle>Hum Psychopharmacol</addtitle><date>2005-04</date><risdate>2005</risdate><volume>20</volume><issue>3</issue><spage>203</spage><epage>205</epage><pages>203-205</pages><issn>0885-6222</issn><eissn>1099-1077</eissn><abstract>This is a report on a case series of five patiens with psychosis in Parkinson's disease who were treated successfully with an intramuscular injection of ziprasidone (10–20 mg) for acute agitation. No deterioration of motor function or other clinically relevant side effects were seen. Copyright © 2005 John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>15799011</pmid><doi>10.1002/hup.682</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-6222 |
| ispartof | Human psychopharmacology, 2005-04, Vol.20 (3), p.203-205 |
| issn | 0885-6222 1099-1077 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_19431692 |
| source | Wiley-Blackwell Read & Publish Collection |
| subjects | Aged Antiparkinson Agents - therapeutic use Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Electrocardiography Emergency Medical Services Female Humans Injections, Intramuscular Male Middle Aged neuroleptic Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - psychology Parkinson's disease Piperazines - administration & dosage Piperazines - adverse effects Piperazines - therapeutic use Psychiatric Status Rating Scales Psychomotor Agitation - drug therapy Psychomotor Agitation - etiology psychosis Psychotic Disorders - drug therapy Psychotic Disorders - etiology Psychotic Disorders - psychology Thiazoles - administration & dosage Thiazoles - adverse effects Thiazoles - therapeutic use treatment ziprasidone |
| title | Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease? |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A34%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parenteral%20ziprasidone:%20a%20new%20atypical%20neuroleptic%20for%20emergency%20treatment%20of%20psychosis%20in%20Parkinson's%20disease?&rft.jtitle=Human%20psychopharmacology&rft.au=Oechsner,%20Matthias&rft.date=2005-04&rft.volume=20&rft.issue=3&rft.spage=203&rft.epage=205&rft.pages=203-205&rft.issn=0885-6222&rft.eissn=1099-1077&rft_id=info:doi/10.1002/hup.682&rft_dat=%3Cproquest_cross%3E19431692%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3792-334832513cad86d58403932b9062a6de4000b37f59677b86da8d4871f7d77bec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19431692&rft_id=info:pmid/15799011&rfr_iscdi=true |